BioCryst Pharmaceuticals, Inc. EPS Growth (basic)

EPS Growth (basic) of BCRX for past 10 years: annual, quarterly and twelve month trailing (TTM) including EPS Growth (basic) growth rates and interactive chart. Year over year growth in basic earnings per share.


Highlights and Quick Summary

  • EPS Growth (basic) for the quarter ending September 30, 2022 was 30.3% (a -190.91% decrease compared to previous quarter)
  • Year-over-year quarterly EPS Growth (basic) decreased by -57.08%
  • Annual EPS Growth (basic) for 2021 was 5.5% (a -134.46% decrease from previous year)
  • Annual EPS Growth (basic) for 2020 was -15.96% (a -491.18% decrease from previous year)
  • Annual EPS Growth (basic) for 2019 was 4.08% (a -115.91% decrease from previous year)
  • Twelve month EPS Growth (basic) ending September 30, 2022 was 17.32% (a 315.35% increase compared to previous quarter)
  • Twelve month trailing EPS Growth (basic) increased by 274.08% year-over-year
Trailing EPS Growth (basic) for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
17.32% 4.17% 10.83% 4.63%
Visit stockrow.com/BCRX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EPS Growth (basic) of BioCryst Pharmaceuticals, Inc.

Most recent EPS Growth (basic)of BCRX including historical data for past 10 years.

Interactive Chart of EPS Growth (basic) of BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. EPS Growth (basic) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 30.3% -33.33% -11.11%
2021 70.59% -26.92% 0.0% -50.0% 5.5%
2020 -1600.0% 23.53% 29.41% 14.29% -15.96%
2019 92.0% -21.43% -78.95% -7.69% 4.08%
2018 -25.0% -55.56% 9.52% -36.84% -25.64%
2017 -233.33% -12.5% 4.55% 38.71% -4.0%
2016 76.0% 20.0% -414.29% -47.62% -27.12%
2015 -56.25% -66.67% 130.43% -23.53% 13.24%
2014 -77.78% 14.29% 0.0% -88.89% -23.64%
2013 59.09% 26.32% 8.0% 30.77% 30.38%
2012 24.14% 40.63% 30.56% 55.17% 37.3%

Business Profile of BioCryst Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology